Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Semaglutide Reduces Hospital Admissions in Patients with Obesity or Overweight and Established CVD
Steven J. Nicholls1; Donna Ryan2; John Deanfield3; Daniel Ferreira4; Anna Koroleva5; Chim C. Lang6; A. Michael Lincoff7; Ildiko Lingvay8; Christopher Lübker5; Katherine Madsen5; Paula Pérez Terns9; Søren Rasmussen5; Peter E. Weeke5; Steven E. Kahn10
MATERIALS AVAILABLE
Slide
19:30 - 20:30
CST
Poster-095
POSTER
Semaglutide effect on knee osteoarthritis pain and walking distance by age, sex and weight loss
Harold Bays1; Sébastien Czernichow2; Joanna Udden Hemmingson3; Thomas Hoffmann Morville4; Anna Koroleva4; Chaithra Shaji5; Boris Stevenin6; Jøran Hjelmesæth7; Sean Wharton8; Henning Bliddal9;
MATERIALS AVAILABLE
Slide
Poster, Infographic
Poster, Infographic
19:30 - 20:30
CST
Poster-106
POSTER
A Real-World Analysis of Clinical Outcomes in Patients Using Semaglutide 2.4 mg for 12 Months
Aleksandrina Ruseva1; Wojciech Michalak1; Anthony Fabricatore1; Bríain ó Hartaigh1; Zhenxiang Zhao1; Devika Umashanker 2
MATERIALS AVAILABLE
Poster
19:30 - 20:30
CST
Poster-089
POSTER
Heart Failure and Obesity (HERO): The Epidemiology and Clinical Burden
Effects of Semaglutide 2.4 mg on Healthcare Costs in Patients with Obesity and Atherosclerotic Cardiovascular Disease (SHINE-ASCVD)
Wojciech Michalak1; Zhenxiang Zhao1; Nana Boame2; Mads Faurby1; Sara Alvarez1
MATERIALS AVAILABLE
Poster
19:30 - 20:30
CST
Poster-096
POSTER
Change in BMI and disease burden among people with obesity and multiple long-term conditions
Kamlesh Khunti1; Alex Mourer2; Silvia Capucci2; Lua Wilkinson3; Abd A. Tahrani2*; Camilla S. Morgen2*; *Joint last authors.
MATERIALS AVAILABLE
Poster
19:30 - 20:30
CST
Poster-118
POSTER
Targeted interventions in obesity: a novel population-level system dynamics approach
Joshua Toliver1; Mads Faurby1; Thomas Padgett2; Phil McEwan2
MATERIALS AVAILABLE
Poster
Monday, 04 November 2024
10:00 - 11:30
CST
ORAL PRESENTATION
SELECT Cardiovascular Outcome Trial: Old Lessons and New Learnings - Dedicated Session
Donna Ryan1; Robert Kushner2; A. Michael Lincoff3; Ildiko Lingvay4; Jorge Plutzky5
MATERIALS AVAILABLE
Slide
Poster
14:30 - 15:30
CST
Poster-423
POSTER
Real-world life expectancy and cardiovascular event-free life-year gains with semaglutide in the UK
Thomas van Sloten1; Steven Hageman1; Jan Westerink1,2; Silvia Capucci3; Marion Escafit4; João Diogo da Rocha Fernandes3; Sara Holloway5; Andrew Pijper5; Natalie Tikhonovsky5; Scott Emerson6; A. Michael Lincoff7; Jorge Plutzky8; Ildiko Lingvay9,10
MATERIALS AVAILABLE
Slide
Video
Tuesday, 05 November 2024
14:30 - 15:30
CST
Poster-487
POSTER
Impact of obesity on health-related quality of life by body mass index and comorbidities: a real-world UK survey
Andrea Leith1; Lewis Harrison1; Hannah Jones1; João Diogo da Rocha Fernandes2; Lise Meinicke Hagelund3; Christopher Lübker2; Silvia Capucci2
MATERIALS AVAILABLE
Slide
Video
14:30 - 15:30
CST
Poster-569
POSTER
CagriSema Targets and Activates Key CNS Regions Involved in Appetite Regulation in Rats
Sofia Lundh1; Anna Secher1; Rune Ehrenreich Kuhre1; Wouter Hogendorf2; Joakim Holck Andersen2; David Ipsen1; Marina Kjærgaard Gerstenberg3; Kirsten Raun1
MATERIALS AVAILABLE
Poster
14:30 - 15:30
CST
Poster-616
POSTER
ACTION-China: Attitudes to weight-management options in people living with obesity and healthcare professionals
Efficacy and safety of oral semaglutide 25 mg in adults with overweight/obesity: the OASIS 4 RCT
W. Timothy Garvey1; Ruben Duque do Vale2; Tobias Karlsson2; Ildiko Lingvay3; Chaithra Shaji4; Domenica Rubino5;
MATERIALS AVAILABLE
Slide
11:00 - 11:15
CST
ORAL PRESENTATION
Spatiocellular Mapping of Neuronal Populations Targeted by Amylin and GLP1 in Human CNS
Sofia Lundh1; Georgina Dowsett2; Mette Ludwig3; Lukas Steuernagel4; Anna Secher1; Brian Lam2; John Tadross2; Henning Hvid1; Charles Pyke1; Jens Brüning4; Giles Yeo2; Kirsten Raun1;
MATERIALS AVAILABLE
Slide
11:15 - 11:30
CST
ORAL PRESENTATION
Effects of Semaglutide 2.4 mg on Healthcare Costs in Patients with Obesity and Heart Failure
Wojciech Michalak1; Zhenxiang Zhao1; Nana Boame2; Mads Faurby1; Sara Alvarez2